Results 71 to 80 of about 237,935 (242)
Management of Postmenopausal Vaginal Atrophy: Review of Literature
AimAs there is dilemma for treatment of postmenopausal vaginal atrophy, effort has been made to review the literature for the same.BackgroundAbout half of all postmenopausal women will experience symptoms related to urogenital atrophy.
Preeti Yadav, Meena Dayal
core +1 more source
The effects of royal jelly on human health: A narrative review of clinical studies
Abstract Royal jelly (RJ) is a natural bioactive substance with documented effects on human health. This narrative review synthesizes evidence from clinical and clinically relevant experimental studies evaluating the therapeutic potential of RJ.
Georgios Goras +2 more
wiley +1 more source
Postmenopausal vaginal atrophy: evaluation of treatment with local estrogen therapy
Mary Jane Minkin,1 Ricardo Maamari,2 Suzanne Reiter3 1Department of Gynecology and Reproductive Medicine, Yale University School of Medicine, New Haven, CT, USA; 2Novo Nordisk Inc., Plainsboro, NJ, USA; 3Mid-County Health Center, Largo, FL, USA Abstract:
Minkin MJ, Maamari R, Reiter S
core
Intravaginally applied oxytocin improves post-menopausal vaginal atrophy
OBJECTIVE: To explore the efficacy of local oxytocin for the treatment of post-menopausal vaginal atrophy. DESIGN: Double-blinded randomised controlled trial. SETTING: Healthy post-menopausal women in Stockholm, Sweden.
Jonasson, AF +2 more
core +1 more source
Anticancer potential of berberine: Molecular pathways and current clinical trial perspectives
Abstract Cancer is constantly rising mortality rates due to its late prognosis, poor management, and expensive treatment. Multi‐sectoral approaches for cancer management include hygienic practices, synthetic drug exploitation, radiation therapy, and diet modifications.
Muhammad Maaz +10 more
wiley +1 more source
SA Kingsberg¹, S Kellogg², M Krychman³1University Hospitals Case Medical Center, Case Western Reserve University Cleveland OH, USA; 2The Pelvic and Sexual Health Institute of Philadelphia, Drexel University College of Medicine,
SA Kingsberg, M Krychman, S Kellogg
core
Cerebral atrophy in mild cognitive impairment and Alzheimer disease: rates and acceleration. [PDF]
OBJECTIVE: To quantify the regional and global cerebral atrophy rates and assess acceleration rates in healthy controls, subjects with mild cognitive impairment (MCI), and subjects with mild Alzheimer disease (AD).
Manning, Emily N +16 more
core +1 more source
Assessment and optimisation of MRI measures of atrophy as potential markers of disease progression in multiple sclerosis [PDF]
There is a need for sensitive measures of disease progression in multiple sclerosis (MS) to monitor treatment effects and understand disease evolution. MRI measures of brain atrophy have been proposed for this purpose. This thesis investigates a number
Anderson, V.
core
Medical and patient attitude towards vaginal atrophy: the AGATA study
To provide data on current management of vaginal atrophy (VA) in a nationwide ...
Palma, F +3 more
core +1 more source
ABSTRACT This retrospective study aimed to explore the value of DAT‐FAT serological profiles confirmed by AET in classifying neonatal jaundice, evaluating its severity, and guiding clinical management. A total of 915 jaundiced newborns (584 pathological, 331 physiological) admitted from July 2018 to August 2021 were included.
Tian‐Ge Wu +7 more
wiley +1 more source

